Understanding the pathophysiology of idiopathic intracranial hypertension (IIH): a review of recent developments Blake D Colman, Frederique Boonstra, Minh NL Nguyen, Subahari Raviskanthan, Priya Sumithran, Owen White, Elspeth J Hutton, Joanne Fielding, Anneke van der Walt
13 March 2024
Exercise as medicine in Parkinson’s disease Martin Langeskov-Christensen, Erika Franzén, Lars Grøndahl Hvid, Ulrik Dalgas
16 October 2024
Pain and functional neurological disorder: a systematic review and meta-analysis Moritz Steinruecke, Isabel Mason, Mairi Keen, Laura McWhirter, Alan J Carson, Jon Stone, Ingrid Hoeritzauer
16 August 2024
Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies Pietro Emiliano Doneddu, Dario Cocito, Raffaella Fazio, Luana Benedetti, Erdita Peci, Giuseppe Liberatore, Yuri Matteo Falzone, Francesco Germano, Francesca Gallia, Claudia Giannotta, Cinta Lleixà, Elisa Bianchi, Eduardo Nobile-Orazio
16 August 2024
Novel therapies in CIDP Devan Mair, Heba Madi, Filip Eftimov, Michael P Lunn, Stephen Keddie
16 December 2024
NICE guideline on ME/CFS: robust advice based on a thorough review of the evidence Peter Walter Barry, Kate Kelley, Toni Tan, Ilora Finlay
17 June 2024
Genetics of inherited peripheral neuropathies and the next frontier: looking backwards to progress forwards Jevin M Parmar, Nigel G Laing, Marina L Kennerson, Gianina Ravenscroft
16 October 2024
Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse Benjamin P Trewin, Russell C Dale, Jessica Qiu, Melissa Chu, Niroshan Jeyakumar, Fionna Dela Cruz, Jane Andersen, Pakeeran Siriratnam, Kit Kwan M Ma, Todd A Hardy, Anneke van der Walt, Jeanette Lechner-Scott, Helmut Butzkueven, Simon A Broadley, Michael H BarnettSee the full list of authors
16 October 2024
Head trauma results in manyfold increased risk of multiple sclerosis in genetically susceptible individuals Eva Johansson, Lars Alfredsson, Pernilla Strid, Ingrid Kockum, Tomas Olsson, Anna Karin Hedström
14 May 2024
Vestibular neurology for the generalist Mohammad Mahmud, Diego Kaski
18 November 2024
Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer’s disease Ruth Dobson, Katherine Patterson, Reshad Malik, Uttara Mandal, Hina Asif, Ros Humphreys, Michael Payne, Eng O-Charoenrat, Lauren Huzzey, Adam Clare, Kate Green, Maija Morton, Catrin Sohrabi, Navreen Singh, Amirtha PasupathySee the full list of authors
16 August 2024
Prevalence of autoimmune diseases in functional neurological disorder: influence of psychiatric comorbidities and biological sex Anna Joseph, Gaston Baslet, Mary A O’Neal, Ginger Polich, Irene Gonsalvez, Andrea N Christoforou, Barbara A Dworetzky, Primavera A Spagnolo
16 August 2024
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world Edoardo Caronna, Victor José Gallardo, Gabriella Egeo, Manuel Millán Vázquez, Candela Nieves Castellanos, Javier A Membrilla, Gloria Vaghi, Joana Rodríguez-Montolio, Neus Fabregat Fabra, Francisco Sánchez-Caballero, Alex Jaimes Sánchez, Albert Muñoz-Vendrell, Renato Oliveira, Gabriel Gárate, Yésica González-OsorioSee the full list of authors
17 September 2024
Phase 1 study of safety and preliminary efficacy of intranasal transplantation of human neural stem cells (ANGE-S003) in Parkinson’s disease Shenzhong Jiang, Han Wang, Chengxian Yang, Feng Feng, Dan Xu, Mengyu Zhang, Manqing Xie, Ruixue Cui, Zhaohui Zhu, Chenhao Jia, Linwen Liu, Lin Wang, Xunzhe Yang, Yingmai Yang, Honglin HaoSee the full list of authors
18 November 2024
Induction cyclophosphamide with maintenance immunosuppression in high-risk myasthenia gravis: long-term follow-up and safety profile Fiona Chan, Todd A Hardy, Sameer Malik, Sudarshini Ramanathan, D Sean Riminton, Stephen W Reddel
18 November 2024
Risk of stroke with different levels of leisure-time physical activity: a systematic review and meta-analysis of prospective cohort studies Federico De Santis, Michele Romoli, Matteo Foschi, Francesco Domenico Sciancalepore, Lucio D'Anna, Lorenzo Barba, Samir Abu-Rumeileh, Simona Sacco, Raffaele Ornello
14 May 2024
Association between heavy alcohol consumption and cryptogenic ischaemic stroke in young adults: a case–control study Nicolas Martinez-Majander, Shakar Kutal, Pauli Ylikotila, Nilufer Yesilot, Lauri Tulkki, Marialuisa Zedde, Tomi Sarkanen, Ulla Junttola, Annika Nordanstig, Annette Fromm, Kristina Ryliskiene, Radim Licenik, Phillip Ferdinand, Dalius Jatuzis, Liisa KõrvSee the full list of authors
16 January 2025
Pathogenesis of multiple sclerosis: genetic, environmental and random mechanisms Douglas S Goodin
16 October 2024
Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study Luis Querol, Jérôme De Sèze, Tina Dysgaard, Todd Levine, T Hemanth Rao, Michael Rivner, Hans-Peter Hartung, Peter Kiessling, Saori Shimizu, Dominika Marmol, Ali Bozorg, Anny-Odile Colson, Ute Massow, Filip Eftimov
16 August 2024
Epidemiology of myasthenia gravis in Denmark, Finland and Sweden: a population-based observational study John Vissing, Sari Atula, Mari Savolainen, Juha Mehtälä, Laila Mehkri, Tina Bech Olesen, Tero Ylisaukko-oja, Ingrid Lindberg-Schager, Fredrik Berggren, Fredrik Piehl
17 September 2024